JHL Biotech to develop monoclonal antibody manufacturing plant at Biolake12 Mar 2013
JHL Biotech and Biolake signed a long-term cooperation strategy agreement on March 2, 2013. Biolake is situated in Wuhan's East High-Tech Zone and brings together executive offices, culture, entertainment, research and development.
Mayor of Wuhan City meets Co-founder of JHL Biotech15 Oct 2012
Hubei provincial party member meets with JHL Biotech Co-founder16 May 2012
On May 16, 2012, Yong Yue, Deputy Secretary-General of the Hubei provincial party committee met with Racho Jordanov, Co-founder, President and CEO of JHL Biotech and James Huang, JHL Biotech Chairman and Partner of Kleiner Perkins Caufield& Byers (KPCB) China Fund to discuss the possibility of JHL Biotech joining Biolake.